论文信息 - Phase 1 Dose-Escalation/Expansion Study of the p38/Tie2 Inhibitor ARRY-614 in Patients with IPSS Low/Int-1 Risk Myelodysplastic Syndromes - 字舞流文

Phase 1 Dose-Escalation/Expansion Study of the p38/Tie2 Inhibitor ARRY-614 in Patients with IPSS Low/Int-1 Risk Myelodysplastic Syndromes

H. Kantarjian | G. Garcia-Manero | E. Jabbour | J. Lancet | H. Khoury | Selena A Rush | A. List | R. Komrokji | M. Foudray | S. Winski | S. Bell | L. Maloney | A. Ptaszynski